The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Noninvasive identification of emergent mutations following cytotoxic therapy for lung cancer.
 
Everett James Moding
Consulting or Advisory Role - DeciBio
 
Angela B. Hui
No Relationships to Disclose
 
Yonina R. Murciano-Goroff
Travel, Accommodations, Expenses - AstraZeneca
 
Barzin Nabet
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
Patents, Royalties, Other Intellectual Property - I have a patent pending related to immunomodulatory nucleic acids. (Inst); Provisional patent related to noninvasive means to predict immune checkpoint blockade outcomes. (Inst)
 
Andre Schultz
Employment - Unimed (I)
Stock and Other Ownership Interests - 10X Genomics; GlaxoSmithKline
 
Yawei Qiao
No Relationships to Disclose
 
Bob T. Li
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bolt Biotherapeutics (Inst); Daiichi Sankyo (Inst); GRAIL (Inst); Guardant Health (Inst); Hengrui Therapeutics (Inst); Lilly (Inst); MORE Health (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Karger Publishers - Book royalty; Shanghai Jiao Tong University Press - Book royalty; US62/514,661 (Inst); US62/685,057 (Inst)
Travel, Accommodations, Expenses - Jiangsu Hengrui Medicine; MORE Health
(OPTIONAL) Uncompensated Relationships - Amgen; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Genentech; Lilly
 
Steven H. Lin
Employment - MD Anderson Cancer Center
Honoraria - AstraZeneca/MedImmune; BeyondSpring Pharmaceuticals
Speakers' Bureau - AstraZeneca
Research Funding - BeyondSpring Pharmaceuticals; Hitachi Chemical; Nektar
Travel, Accommodations, Expenses - Elekta; STCube Pharmaceuticals Inc.
 
Ash A. Alizadeh
Leadership - Lymphoma Research Foundation
Stock and Other Ownership Interests - CAPP Medical; CiberMed; Forty Seven
Honoraria - Janssen Oncology; Janssen Oncology; Roche
Consulting or Advisory Role - Celgene; Cibermed; Foresight Diagnostics; Foresight Diagnostics; Foresight Diagnostics; Gilead Sciences; Roche/Genentech
Research Funding - Celgene
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection, assigned to Stanford University. (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
Maximilian Diehn
Stock and Other Ownership Interests - CiberMed; Foresight Diagnostics
Consulting or Advisory Role - AstraZeneca; BioNTech; Genentech; Gritstone Bio; Illumina; Novartis; Reflexion Medical; Roche
Research Funding - Illumina; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection assigned to Stanford University (Inst); Patent filings on tumor treatment resistance mechanisms assigned to Stanford University (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche; Varian Medical Systems